510(k) K212933

INHANCETM Hybrid Anatomic Glenoid Implant by Depuy Ireland UC — Product Code MBF

K212933 is an FDA 510(k) premarket notification submitted by Depuy Ireland UC for the device "INHANCETM Hybrid Anatomic Glenoid Implant". The FDA issued a decision of Substantially Equivalent on June 8, 2022. The device falls under product code MBF (Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented), a Class II device regulated under 21 CFR 888.3670. Depuy Ireland UC has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 8, 2022
Date Received
September 15, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented
Device Class
Class II
Regulation Number
888.3670
Review Panel
OR
Submission Type